LISATA THERAPEUTICS, INC. (LSTA) — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024)

$1.0M

Net Income/Loss (FY2024)

-$20.0M

Total Assets (FY2024)

$35.0M

Total Equity (FY2024)

$29.3M

Cash Flows from Operating Activities (FY2024)

-$19.4M

Source: LISATA THERAPEUTICS, INC. 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.